Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Int J Biol Markers. 2011 Jan-Mar;26(1):1-8. doi: 10.5301/jbm.2011.6267.
Metastasis is a complex process divided into a number of steps including detachment of tumor cells from the primary tumor, invasion, migration, intravasation, survival in the vasculature, extravasation, and colonization of the secondary site. Proteins that block metastasis without inhibiting primary tumor formation are known as metastasis suppressors; examples are NM23, Maspin, KAI1, KISS1, and MKK4. Breast cancer metastasis suppressor 1 (BRMS1) was identified as a suppressor of breast cancer metastasis in the late 1990s. In vitro and in vivo studies have confirmed that BRMS1 is a potent metastasis suppressor not limited to breast cancer. However, conflicting clinical observations regarding its role as a metastasis suppressor and its validity as a diagnostic biomarker warrant more in-depth clinical study. In this review, the authors provide an overview of its biology, function, action mechanism and pathological significance.
转移是一个复杂的过程,可分为多个步骤,包括肿瘤细胞从原发性肿瘤上脱离、侵袭、迁移、内渗、在脉管系统中存活、外渗以及继发性部位的定植。能够抑制转移而不抑制原发性肿瘤形成的蛋白质被称为转移抑制因子;例如 NM23、Maspin、KAI1、KISS1 和 MKK4。乳腺癌转移抑制因子 1(BRMS1)在 20 世纪 90 年代后期被确定为乳腺癌转移的抑制因子。体外和体内研究证实,BRMS1 是一种有效的转移抑制因子,不仅限于乳腺癌。然而,关于其作为转移抑制因子的作用以及作为诊断生物标志物的有效性的临床观察结果相互矛盾,需要更深入的临床研究。在这篇综述中,作者提供了其生物学、功能、作用机制和病理学意义的概述。